Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norio Watanabe

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
The Cochrane Database of Systematic Reviews|April 4, 2014
Paroxetine versus other anti-depressive agents for depressionMarianna Purgato, Davide Papola, Chiara Gastaldon, et al.
The Cochrane Database of Systematic Reviews|June 30, 2022
Certolizumab pegol for maintenance of medically induced remission in Crohn's diseaseShinji Okabayashi, Hajime Yamazaki, Ryohei Yamamoto, et al.
Schizophrenia Research|September 15, 2010
Psychotic-like experiences are associated with violent behavior in adolescentsYoshihiro Kinoshita, Shinji Shimodera, Atsushi Nishida, et al.
Trials|February 1, 2015
A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trialNorio Watanabe, Toshi A Furukawa, Masaru Horikoshi, et al.
Lower Urinary Tract Symptoms|July 4, 2020
Clinical feasibility and acceptability of adding cognitive behavioral therapy to pharmacotherapy for drug-resistant overactive bladder in women: A single-arm pilot studySatoshi Funada, Norio Watanabe, Takayuki Goto, et al.
The Cochrane Database of Systematic Reviews|September 3, 2019
Certolizumab pegol for induction of remission in Crohn's diseaseHajime Yamazaki, Ryuhei So, Katsuyoshi Matsuoka, et al.
The Journal of Urology|May 13, 2020
Impact of Nocturia on Mortality: The Nagahama StudySatoshi Funada, Yasuharu Tabara, Kazuya Setoh, et al.
Neuropsychopharmacology Reports|November 22, 2021
Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnoticsYumi Aoki, Yoshikazu Takaesu, Masahiro Suzuki, et al.
Journal of Neuromuscular Diseases|October 24, 2019
Caregiver Burden and Related Factors Among Caregivers of Patients with Myotonic Dystrophy Type 1Go Kurauchi, Makiko Endo, Kaori Odaira, et al.
Neuropsychiatric Disease and Treatment|January 26, 2019
Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1Makiko Endo, Kaori Odaira, Ryohei Ono, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
The Cochrane Database of Systematic Reviews|April 4, 2014
Paroxetine versus other anti-depressive agents for depressionMarianna Purgato, Davide Papola, Chiara Gastaldon, et al.
The Cochrane Database of Systematic Reviews|June 30, 2022
Certolizumab pegol for maintenance of medically induced remission in Crohn's diseaseShinji Okabayashi, Hajime Yamazaki, Ryohei Yamamoto, et al.
Schizophrenia Research|September 15, 2010
Psychotic-like experiences are associated with violent behavior in adolescentsYoshihiro Kinoshita, Shinji Shimodera, Atsushi Nishida, et al.
Trials|February 1, 2015
A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trialNorio Watanabe, Toshi A Furukawa, Masaru Horikoshi, et al.
Lower Urinary Tract Symptoms|July 4, 2020
Clinical feasibility and acceptability of adding cognitive behavioral therapy to pharmacotherapy for drug-resistant overactive bladder in women: A single-arm pilot studySatoshi Funada, Norio Watanabe, Takayuki Goto, et al.
The Cochrane Database of Systematic Reviews|September 3, 2019
Certolizumab pegol for induction of remission in Crohn's diseaseHajime Yamazaki, Ryuhei So, Katsuyoshi Matsuoka, et al.
The Journal of Urology|May 13, 2020
Impact of Nocturia on Mortality: The Nagahama StudySatoshi Funada, Yasuharu Tabara, Kazuya Setoh, et al.
Neuropsychopharmacology Reports|November 22, 2021
Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnoticsYumi Aoki, Yoshikazu Takaesu, Masahiro Suzuki, et al.
Journal of Neuromuscular Diseases|October 24, 2019
Caregiver Burden and Related Factors Among Caregivers of Patients with Myotonic Dystrophy Type 1Go Kurauchi, Makiko Endo, Kaori Odaira, et al.
Neuropsychiatric Disease and Treatment|January 26, 2019
Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1Makiko Endo, Kaori Odaira, Ryohei Ono, et al.
Pageof 16